Episode 59: Opening Doors to Treatment: Therapies for Gastrointestinal Stromal Tumors

Posted Friday, July 7, 2023

Host: Wendy Vogel, MSN, FNP, AOCNP^®

Guests: Sandra Brackert, NP, and Kathleen Polson, NP

Gastrointestinal stromal tumors (GISTs) are considered rare, yet they represent the most common sarcomas of the gastrointestinal tract. Sandra Brackert, NP, of UCLA Sarcoma Center, and Kathleen Polson, NP, of Dana-Farber Cancer Institute, speak with host Wendy Vogel, MSN, FNP, AOCNP®, on the effective management of patients with GIST who have progressed on multiple therapies. 

Related Content: 

Management of Patients With Advanced Gastrointestinal Stromal Tumor: Emphasis on Fourth-Line Treatment With Ripretinib. J Adv Pract Oncol 2023;14(4):317–328. https://doi.org/10.6004/jadpro.2023.14.4.6

GIST Support International: https://www.gistsupport.org/ 

GIST Cancer Research Fund: https://gistinfo.org/ 

The Life Raft Group: https://liferaftgroup.org/ 

More from The JADPRO Podcast